Navigation Links
Urologists Begin Clinical Trials on Treatment of Peyronies Disease

Urologists have recently initiated large scale clinical trials in order to substantiate preliminary results. Pre-Trial Results The previous clinical studies by X4 Labs Inc. were a small scale study which not only looked at the effect of the device on penis curvature but also at its potential as a non-surgical penis enlargement product.

In the clinical trials conducted by the research and development firm, the penis extender was shown to correct Peyronies disease up to 70 percent and results were significantly higher in milder cases. The previous studies also showed significant promise for the penis extender as a non-surgical penile augmentation device.

The controlled sample indicated that males using the penis stretcher for approximately three to six months experienced an increase in penis size of approximately 2.5 inches, with minor variations amongst participants. Urological Trials to Be Conducted The previous clinical trials conducted by X4 Labs Inc. have led to a distinct interest by the urological community, particularly in the use of these devices as an alternative to traditional surgical procedures for the correction of penis curvature.

The penis extender works on the principle of traction, which in essence means that as tension is applied to the penis body it forces cellular division and the creation of new skin tissue. A clinical study will be launched in the upcoming months by the International Andrological Association aimed at substantiating the use of these devices on a wider scale.

As pervasive surgery on the penis can often have drastic side effects such as impotence and loss of sensitivity, the penis extender will be a valuable tool in mild cases of penis curvature. These results will allow for greater use of non-surgical penis extenders within urological clinics. Already medically certified, results of this study may increase urologists prescription of non-surgical devices for the treatment of mild cases of penile curvature.

For Mor Information Please Contact:- Adam Griffin,


Related medicine news :

1. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
2. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
3. Cancer Begins With Epigenetic Changes: Study
4. Learning About Healthy Diet Choices Begins At Schools
5. China Begins Human Trials For HIV/AIDS Drug
6. Pilot Study to Test Effect of Mobile Phone Transmissions On Skin To Begin In Finland
7. Preparation for Culling Begin at Belghat, Rajangaon and Dhaamnia
8. Make-Up Tips For Beginners
9. Jalgaon: Third Phase Of Culling Operations Begin
10. Human Bird Flu Vaccine Trials Begin In Russia
11. Administration of Fish Drug for Asthma Patients Begins in Andhra
Post Your Comments:

(Date:11/25/2015)... Missouri (PRWEB) , ... November 25, 2015 , ... ... HEAL, will provide scholarships for people struggling with eating disorders as a result ... from the second annual event, held at Fox Run Golf Club in Eureka, ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination of recycled ... way for homeless people to have a more dignified and comfortable night’s sleep. ... they are repurposing plastic bags into sleeping mats for the homeless. The ...
(Date:11/25/2015)... Mateo, CA (PRWEB) , ... November 25, 2015 , ... ... in prizes were awarded to winners of the Create Real Impact awards. California ... creative expression to help stem the tide of distracted and reckless driving, the number ...
(Date:11/24/2015)... GA (PRWEB) , ... November 24, 2015 , ... Dr. ... to now offer laser services to many of his patients. Dr. Afferica now uses ... designed to reduce the amount of time the doctor uses other traditional cutting tools, ...
(Date:11/24/2015)... SAN FRANCISCO, CA (PRWEB) , ... November 24, ... ... launched half-cup sizes, has launched their Black Friday sale a week early, offering ... ThirdLove continues to transform the intimate apparel industry through both mobile fit technology ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Investors"), pursuant to which BioLight and the New Investors ... Ltd. subsidiary ("IOPtima") via a private placement. The financing ... its innovative IOPtimate™ system used in the treatment of ... pathway process for the IOPtimate™ system with the U.S. ...
(Date:11/25/2015)... 25, 2015 --> ... eine Lizenz für das Patent über eine neue Hepatitis-B-Behandlung, ... ENS-Lyon innehaben, an Enyo Pharma vergeben haben. ... Leben gerufenen und von Edelris gemeinsam mit seinen Partnern ... Behandlungsziel für HBV identifiziert, und es wurden neue Inhaltsstoffe ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 /PRNewswire/ ... leader in non-invasive genetic testing and the ... that it will present at the 27 ... York on Wednesday, December 2, 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, ... Company,s financial results, business activities and financial ...
Breaking Medicine Technology: